Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Accor
Accor Increases at 49% its Stake in Groupe Lucien Barriere
April 17th, 2009
Under the agreements signed in January 2004 between Colony Capital, the Desseigne Barriere family and Accor, Colony Capital had an option to sell Accor its 15% stake in Groupe Lucien Barriere SAS, at a price determined by five independent banks. In November 2008, Colony Capital announced its intention to start the valuation process. The resulting valuation of EUR 153 million is the average of the valuations made by the independent experts, excluding the highest and the lowest valuations, in accordance with the agreements signed in 2004. Following this valuation process, Colony Capital decided to exercise the...
Source: Health Business Week (2009-04-17)
|
